Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Adalimumab Products

(Adalimumab)

Categories

antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.

Recommended Adalimumab Antibodies

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application
Validations
Cat. No. ABIN7482167
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application
Validations
Cat. No. ABIN7482166
Quantity 200 μg
Datasheet Datasheet

Recommended Adalimumab ELISA Kits

Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity Chemical, Human
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
Cat. No. ABIN2862650
Quantity 96 tests
Datasheet Datasheet
Reactivity Human, Mouse, Rat
Analytical Method Quantitative Sandwich ELISA
Validations
Cat. No. ABIN4886389
Quantity 96 tests
Datasheet Datasheet

Latest Publications for our Adalimumab products

Sugita, Watanabe, Kamata, Yukawa, Otani, Hosomi, Nagami, Tanaka, Taira, Yamagami, Tanigawa, Shiba, Watanabe, Tominaga, Kabata, Shintani, Arakawa, Fujiwara: "Efficacy of a concomitant elemental diet to reduce the loss of response to adalimumab in patients with intractable Crohn's disease." in: Journal of gastroenterology and hepatology, Vol. 33, Issue 3, pp. 631-637, (2018) (PubMed).

Piñero, Juanola, Gutiérrez, Zapater, Giménez, Steinert, Sempere, González-Navajas, Niess, Francés: "IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA." in: Journal of molecular medicine (Berlin, Germany), Vol. 95, Issue 11, pp. 1227-1236, (2018) (PubMed).

Ward, Thwaites, Beswick, Hogg, Rosella, Van Langenberg, Reynolds, Gibson, Sparrow: "Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease." in: Alimentary pharmacology & therapeutics, Vol. 45, Issue 8, pp. 1135-1145, (2017) (PubMed).

Gibellini, De Biasi, Bianchini, Bartolomeo, Fabiano, Manfredini, Ferrari, Albertini, Trenti, Nasi, Pinti, Iannone, Salvarani, Cossarizza, Pellacani: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." in: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).

Song, Kang, Choi, Choe: "Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study." in: Pediatric gastroenterology, hepatology & nutrition, Vol. 19, Issue 2, pp. 116-22, (2016) (PubMed).

Bortlik, Duricova, Machkova, Hruba, Lukas, Mitrova, Romanko, Bina, Malickova, Kolar, Lukas: "Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation." in: Scandinavian journal of gastroenterology, Vol. 51, Issue 2, pp. 196-202, (2016) (PubMed).

Bodini, Giannini, Savarino, Savarino: "Adalimumab trough levels and response to biological treatment in patients with inflammatory bowel disease: a useful cutoff in clinical practice." in: The American journal of gastroenterology, Vol. 110, Issue 3, pp. 472-3, (2015) (PubMed).

Juanola, Moratalla, Gutiérrez, Sempere, Zapater, Giménez, Almenta, Peiró, González-Navajas, Such, Francés: "Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease." in: Journal of gastroenterology, Vol. 50, Issue 7, pp. 758-68, (2015) (PubMed).

Gutiérrez, Scharl, Sempere, Holler, Zapater, Almenta, González-Navajas, Such, Wiest, Rogler, Francés: "Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease." in: Gut, Vol. 63, Issue 2, pp. 272-80, (2014) (PubMed).

Bortlik, Duricova, Machkova, Kozeluhova, Kohout, Hrdlicka, Durilova, Mitrova, Hradsky, Bronsky, Malickova, Lukas: "Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children." in: Inflammatory bowel diseases, Vol. 20, Issue 3, pp. 495-501, (2014) (PubMed).

You are here:
Support